Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects.
about
A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)Multitargeted therapy of cancer by silymarinSilymarin as a Natural Antioxidant: An Overview of the Current Evidence and PerspectivesTreatment of amatoxin poisoning: 20-year retrospective analysisPolyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin.Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailabilitySilymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.Antioxidant properties of silybin glycosides.Silybin and the liver: from basic research to clinical practice.Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies.A New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects.In vitro assessment of hepatoprotective agents against damage induced by acetaminophen and CCl4.Multifocal angiostatic therapy: an update.Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle systemRecent advances in plant hepatoprotectives: a chemical and biological profile of some important leads.Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation.Status of novel drug delivery technology for phytotherapeutics.Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease.Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review.Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer.HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity StudiesIn Vitro Co-Delivery Evaluation of Novel Pegylated Nano-Liposomal Herbal Drugs of Silibinin and Glycyrrhizic Acid (Nano-Phytosome) to Hepatocellular Carcinoma Cells.Oral bioavailability of curcumin: problems and advancements.Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.Impact of Dendrimers on Solubility of Hydrophobic Drug MoleculesEthnopharmacological Approaches for Therapy of Jaundice: Part II. Highly Used Plant Species from Acanthaceae, Euphorbiaceae, Asteraceae, Combretaceae, and Fabaceae Families.An Overview of Ultraviolet B Radiation-Induced Skin Cancer Chemoprevention by SilibininAntioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis.Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid.Absorption enhancement of grape seed polyphenols by complexation with phosphatidyl choline.Consumption of silibinin, a flavonolignan from milk thistle, and mammary cancer development in the C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mouse.The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers.Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.Modulation of cutaneous wound healing by silymarin in rats.Antioxidant and hepatoprotective effects of mixed micellar lipid formulation of phyllanthin and piperine in carbon tetrachloride-induced liver injury in rodents.Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.
P2860
Q24633382-6A501A44-97A4-4802-A7EA-FFB3785EBF31Q24655042-E78C2D04-2E84-4D57-B6B6-AE021296C009Q26770933-57B0DFF2-522E-4D0B-947F-5FDD04DD2E11Q28217079-9A437F5C-CF8B-46E2-9DF3-666958731FF4Q33717351-EDE1163A-111D-49E7-9831-852E4EB12732Q33986021-2C2F091E-9E3F-4132-94E7-E8F15A97733BQ34030782-540F476A-26F3-4DE7-80BD-1DD6DB5E13E1Q34122120-426EAAE0-F379-4063-8E2E-122B6866654CQ34629765-6C269F9E-46E0-4CBC-9228-A0F7CF48CC92Q34634347-66974048-6E7A-45A1-8DCF-C57AB5DA31C3Q35870488-6F9F2524-8219-4722-AF42-048EE192A8D2Q36249424-2561A02F-70F2-4C8E-A18A-71E651B65B60Q36311166-9D464465-3C93-46F2-BED3-BEF5AEC79BD9Q36965584-5B10F4EC-F7AF-4A24-AE6F-5B26F05F6730Q36989714-73D6D78E-331A-40C8-A896-16521247D88AQ37164213-3936F71E-88B0-4C0B-B810-2CA5AF656BEEQ37510870-19300729-9421-4A93-BF3C-63E4695F7930Q38058825-E9FB9CC1-1B3B-4C8C-A2D3-9B345A1C3268Q38341299-1EF13944-0881-40BC-9AB6-DBF6129C0F4FQ38616795-4DD5DC74-000F-4C15-A095-BE60D74B8DC8Q38639870-80354269-2935-444C-8DE1-9F5525AC7405Q38751101-1BC26ADD-A398-473E-B98A-7F8860020B3EQ38760621-D4794960-F9D2-4234-86C8-CC14C09FE59AQ39104518-57D5B24C-E282-443D-9110-A814D1D9D1E8Q39339379-340C6A86-2684-4CE3-B9C4-193E2DCB4C41Q41368968-07218D28-8B87-4A55-BA21-479A79B6970AQ42425295-C3C3181C-BC13-452E-B245-85D615D4ECFCQ42811158-5E3DC2C3-8136-441D-BFA6-825EE277D6C7Q42972727-11CDABFA-8F6A-4A92-8B5E-58B0DD685D5BQ44916279-E19EB80E-3BFA-49C9-A2B7-F07118731B2BQ46971547-A47672CB-0F39-475F-915B-4A18176222BFQ47947039-255BEB65-3C41-4190-8F87-B49AD2BF19D0Q48324641-0AE54723-F20A-4F16-A2DC-547F8DD28C30Q50071437-550633ED-523D-445E-A69B-3863E006F4FCQ51309696-CB9B3AF6-B557-4B32-B6ED-C935041E8DE0Q51786459-E4D38D82-8723-4013-8B18-39E4BC617F5AQ53576959-44E6A833-B815-4295-8E41-DB7672125EF2
P2860
Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects.
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@ast
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@en
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@nl
type
label
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@ast
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@en
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@nl
prefLabel
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@ast
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@en
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@nl
P2093
P356
P1476
Pharmacokinetic studies on IdB ...... ex, in healthy human subjects.
@en
P2093
P2888
P304
P356
10.1007/BF03190223
P577
1990-10-01T00:00:00Z
P6179
1051346564